Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kleva Pharmaceuticals is a well-established Greek pharmaceutical company operating since 1974. It acts as a CDMO with global reach, offering contract manufacturing, technology transfer, R&D services, and commercializing both proprietary prescription and OTC products. The company manufactures a wide range of finished dosage forms including solids, liquids, injectables, nasal preparations, ophthalmics, semi-solids and parenterals. Its portfolio includes generics for various therapeutic areas such as anti-infectives, allergy treatments, anti-inflammatory drugs and more. Kleva holds GMP certification and serves over 90 clients in more than 40 countries[1][2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kleva Pharmaceuticals.